Prudential Financial, Inc. (PRU) 13D/13G Filings for Tarsus Pharmaceuticals, Inc. (TARS)

Prudential Financial, Inc. 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
4:41 pm
Purchase
2024-11-1413GTarsus Pharmaceuticals, Inc.
TARS
PRUDENTIAL FINANCIAL INC
PRU
2,295,400
6.000%
2,295,400increase
(New Position)
Filing